Given the critical role of the TMBIM6-NDUFS4-VDAC1 interaction in mitochondrial homeostasis regulation, exploring potential therapeutics targeting this axis could offer promising treatments for metabolic disorder-related endothelial damage. This evidence concerns the gene VDAC1 and metabolic disease.